实用肝脏病杂志 ›› 2024, Vol. 27 ›› Issue (5): 769-772.doi: 10.3969/j.issn.1672-5069.2024.05.031

• 肝癌 • 上一篇    下一篇

原发性肝癌患者双源CT全肝灌注成像特点及对TACE术后残余病灶的评估价值*

陈海琳, 杨涛, 周云   

  1. 226500 江苏省如皋市中医院放射科(陈海琳);消化科(周云);南通大学附属医院放疗科(杨涛)
  • 收稿日期:2024-03-04 出版日期:2024-09-10 发布日期:2024-09-09
  • 作者简介:陈海琳,女,39岁,大学本科,主管技师。E-mail:chl19871125@163.com
  • 基金资助:
    *江苏省南通市科技计划指导项目(编号:MSZ21025)

Dual-source CT whole liver perfusion image feature in patients with primary liver cancer and evaluation of residual lesions after transcatheter arterial chemoembolization

Chen Hailin, Yang Tao, Zhou Yun   

  1. Department of Radiology, Traditional Chinese Medicine Hospital, Rugao 226500,Jiangsu Province, China
  • Received:2024-03-04 Online:2024-09-10 Published:2024-09-09

摘要: 目的 探讨原发性肝癌(PLC)病灶双源CT全肝灌注成像特点及其评估经肝动脉化疗栓塞术(TACE)后残余病灶的价值。方法 2021年1月~2023年8月我院收治的PLC患者94例,均接受TACE术治疗。使用双源CT机扫描和后处理工作站处理图像,记录感兴趣区血容量(BV)、开始增强时间(TTS)、血流量(BF)、肝动脉灌注量(ALP)、门静脉灌注量(PVP)和肝灌注指数(HPI)。应用受试者工作特征曲线(ROC)评估CT全肝灌注成像参数评估残余病灶的价值。结果 术前,59例病灶ALP为均匀高灌注,35例出现不均匀高灌注,PVP均呈低灌注;术后一个月CT检查显示21例(22.3%)肿瘤病灶被完全栓塞,ALP显示为无血流灌注,73例病灶内出现碘油沉积或部分缺损,ALP呈高灌注;术后,21例病灶完全栓塞区BV、BF、ALP和HPI分别为(5.3±1.2)ml/100 ml、(42.7±7.6)ml/(100 ml·min-1)、(15.1±3.7)ml/(100 ml·min-1)和(19.5±2.1)%,显著低于术前【分别为(11.2±1.9)ml/100ml、(84.4±10.4)ml/(100 ml·min-1)、(38.9±5.7)ml/(100 ml·min-1)和(74.4±8.9)%,P<0.05】,而TTS和PVP分别为(11.9±2.1)s和(45.7±4.5)ml/(100 ml·min-1),均显著大于术前【分别为(6.4±1.4)s和(12.2±2.1)ml/(100 ml·min-1),P<0.05】;TACE术后病灶残余区ALP和HPI分别为(46.1±6.2)ml/(100 ml·min-1)和(81.0±5.9)%,显著大于术前 【分别为(38.5±5.3)ml/(100 ml·min-1)和(75.3±5.6)%,P<0.05】, 而PVP为(7.7±2.5)ml/(100 ml·min-1),显著小于术前【(11.8±2.1)ml/(100 ml·min-1),P<0.05】;经ROC曲线分析显示,多参数联合诊断TACE术后病灶残余区的曲线下面积(AUC)为0.940,其敏感性为87.7%,特异度为89.4%。结论 PLC病灶CT全肝灌注成像呈高灌注,应用成像多参数联合判断TACE术后残余病灶具有很大的临床应用价值

关键词: 原发性肝癌, 双源CT全肝灌注成像, 经肝动脉化疗栓塞术, 残余病灶, 疗效评估

Abstract: Objective The aim of this study was to investigate CT wholeliver perfusion image feature in patients with primary liver cancer (PLC) and evaluation of residual lesions after transcatheter arterial chemoembolization (TACE). Methods 94 patients with PLC were enrolled in our hospital between January 2021 and August 2023, and all underwent TACE therapy. All patients were examined by 128-slice dual-source CT machine before andone month after surgery, and blood volume (BV), blood flow (BF), hepatic artery perfusion volume (ALP), hepatic perfusion index (HPI), starting time (TTS) and portal vein perfusion volume (PVP) were recorded. Receiver operating characteristic curve (ROC) was applied toevaluate efficacy of CTperfusion parameters in evaluating residual lesions after TACE. Results Before TACE, CT scan revealed uniform hyperperfusion in 59 lesions, uneven hyperperfusion in 35 lesions and low perfusion on PVP image; one month after TACE, complete remission was found in 21 cases (22.3%), with low perfusion on ALP image, and lipiodol deposition or partial deposition in 73 cases, with high hyperperfusion on ALP image; one month after TACE, BV,BF, ALP and HPI in 21 complete remission lesions were (5.3±1.2)ml/100 ml, (42.7±7.6)ml/(100 ml·min-1), (15.1±3.7)ml/(100 ml·min-1) and (19.5±2.1)%, all significantly lower than [(11.2±1.9)ml/100ml, (84.4±10.4)ml/(100 ml·min-1), (38.9±5.7)ml/(100 ml·min-1) and (74.4±8.9)%, P<0.05], while TTS and PVP were (11.9±2.1)s and (45.7±4.5)ml/(100 ml·min-1), both significantly greater than [(6.4±1.4)s and (12.2±2.1)ml/(100 ml·min-1), P<0.05] before TACE; after TACE, ALP and HPI in residual lesions were (46.1±6.2)ml/(100 ml·min-1)and (81.0±5.9)%, both much greater than [(38.5±5.3)ml/(100 ml·min-1)and (75.3±5.6)%, P<0.05], while PVP was (7.7±2.5)ml/(100 ml·min-1), much lower than [(11.8±2.1)ml/(100 ml·min-1),P<0.05] before TACE; ROC analysis showed that the AUC was 0.940, with sensitivity of 87.7% and specificity of 89.4%, when combination of CT wholeliver perfusion image parameters in evaluating residual lesions after TACE. Conclusion Primary liver cancer lesions are highly perfused on dual-source CT whole liver perfusion imaging, and combined perfusion imaging parameters has a satisfactory evaluation of residual lesions after TACE.

Key words: Hepatoma, Dual-source CT whole liver perfusion imaging, Transhepatic arterial chemoembolization, Residual lesions, Remission